• Home
  • About Us
    • About Us
    • Leadership Team
  • Science
    • Biologics
    • Biomanufacturing
    • Pipeline
  • Investors
    • Overview
    • SEC Filings
    • Press Releases
    • Presentations
    • Corporate Governance
    • Investor Resources
      semaglutide
      • Email Alerts
      • FAQs
      • Tax Documents
  • Careers
  • Contact Us

Tivic Health Signs Agreement with ALOM to Manage Product Supply Chain, Assembly, and Logistics

Dec 1, 2022 | Press Releases

Significant progress made to supply chain to support cost improvements and scaling SAN FRANCISCO – Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic...

Tivic Health Signs Agreement with ALOM to Manage Product Supply Chain, Assembly, and Logistics

Dec 1, 2022 | Press Releases

Significant progress made to supply chain to support cost improvements and scaling SAN FRANCISCO – Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic...

Tivic Health Reports Third Quarter 2022 Financial Results

Nov 14, 2022 | Press Releases

65% growth in year-to-date revenue 146% increase in unit sales through direct-to-consumer channels for the same period Entered into definitive agreement to acquire Reliefband SAN FRANCISCO – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq:...

Tivic Health Reports Third Quarter 2022 Financial Results

Nov 14, 2022 | Press Releases

65% growth in year-to-date revenue 146% increase in unit sales through direct-to-consumer channels for the same period Entered into definitive agreement to acquire Reliefband SAN FRANCISCO – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq:...

Tivic Health Announces Manufacturing Partnership With Microart

Nov 10, 2022 | Press Releases

Agreement expected to reduce product manufacturing and shipping costs SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into an...
« Older Entries
Next Entries »

Recent Posts

  • Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
  • Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
  • Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird’s National Security Conference
  • Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
  • Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation

Recent Comments

No comments to show.
©2026 Valion Bio

Privacy Policy

For ClearUP customer questions regarding warranty or other device inquiries, please reach out to customerservice@tivichealth.com.